Strategic Wealth Advisors Group, LLC Gilead Sciences, Inc. Transaction History

Strategic Wealth Advisors Group, LLC

$2.33 Billion
Q3 2022

A detailed history of Strategic Wealth Advisors Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Strategic Wealth Advisors Group, LLC holds 36,907 shares of GILD stock, worth $4.42 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

36,907

Previous 42,159 12.46%

Holding current value

$4.42 Million

Previous $2.63 Million 13.55%

% of portfolio

0.1%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $312,704 - $357,188	-5,252 Reduced 12.46%	36,907 $2.28 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $333,563 - $375,692	5,779 Added 15.89%	42,159 $2.63 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $602,599 - $755,122	10,404 Added 40.05%	36,380 $2.13 Million
Q4 2021 Feb 16, 2022	SELL	$64.88 - $73.64 $229,675 - $260,685	-3,540 Reduced 11.99%	25,976 $1.89 Million
Q3 2021 Nov 17, 2021	SELL	$67.69 - $73.03 $178,092 - $192,141	-2,631 Reduced 8.18%	29,516 $2.06 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $119,260 - $130,308	1,879 Added 6.21%	32,147 $2.21 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $300,480 - $342,847	5,008 Added 19.83%	30,268 $1.96 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $56,706 - $64,614	1,001 Added 4.13%	25,260 $1.47 Million
Q3 2020 Nov 30, 2020	BUY	$62.1 - $78.08 $71,725 - $90,182	1,155 Added 5.0%	24,259 $1.53 Million
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $211,377 - $245,448	-2,922 Reduced 11.23%	23,104 $1.77 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $333,567 - $427,251	5,326 Added 25.73%	26,026 $1.89 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $49,973 - $54,969	811 Added 4.08%	20,700 $1.35 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $77,762 - $85,836	-1,244 Reduced 5.89%	19,889 $1.26 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $108,705 - $121,900	-1,757 Reduced 7.68%	21,133 $1.43 Million
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $129,999 - $145,633	-2,079 Reduced 8.33%	22,890 $0
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $181,983 - $237,474	3,006 Added 13.69%	24,969 $1.69 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $1.57 Million - $1.73 Million	21,963 New	21,963 $1.7 Million
Q2 2018 Sep 17, 2018	SELL	$64.88 - $75.68 $4.45 Million - $5.19 Million	-68,590 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $2.59 Million - $3.15 Million	35,506 Added 107.32%	68,590 $5.17 Million
Q4 2017 Mar 08, 2018	BUY	$71.15 - $83.52 $2.35 Million - $2.76 Million	33,084	33,084 $2.37 Million

Others Institutions Holding GILD

# of Institutions

2,347

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $150B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Advisors Group, LLC with notifications on news.

Account

Strategic Wealth Advisors Group, LLC Gilead Sciences, Inc. Transaction History